Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 104

1.

Expanding the spectrum of PEX16 mutations and novel insights into disease mechanisms.

Kumar KR, Wali G, Davis RL, Mallawaarachchi AC, Palmer EE, Gayevskiy V, Minoche AE, Veivers D, Dinger ME, Mackay-Sim A, Cowley MJ, Sue CM.

Mol Genet Metab Rep. 2018 Jul 20;16:46-51. doi: 10.1016/j.ymgmr.2018.07.003. eCollection 2018 Sep.

2.

Patient-Derived Stem Cell Models in SPAST HSP: Disease Modelling and Drug Discovery.

Wali G, Sue CM, Mackay-Sim A.

Brain Sci. 2018 Jul 31;8(8). pii: E142. doi: 10.3390/brainsci8080142. Review.

3.

FANTOM5 CAGE profiles of human and mouse samples.

Noguchi S, Arakawa T, Fukuda S, Furuno M, Hasegawa A, Hori F, Ishikawa-Kato S, Kaida K, Kaiho A, Kanamori-Katayama M, Kawashima T, Kojima M, Kubosaki A, Manabe RI, Murata M, Nagao-Sato S, Nakazato K, Ninomiya N, Nishiyori-Sueki H, Noma S, Saijyo E, Saka A, Sakai M, Simon C, Suzuki N, Tagami M, Watanabe S, Yoshida S, Arner P, Axton RA, Babina M, Baillie JK, Barnett TC, Beckhouse AG, Blumenthal A, Bodega B, Bonetti A, Briggs J, Brombacher F, Carlisle AJ, Clevers HC, Davis CA, Detmar M, Dohi T, Edge ASB, Edinger M, Ehrlund A, Ekwall K, Endoh M, Enomoto H, Eslami A, Fagiolini M, Fairbairn L, Farach-Carson MC, Faulkner GJ, Ferrai C, Fisher ME, Forrester LM, Fujita R, Furusawa JI, Geijtenbeek TB, Gingeras T, Goldowitz D, Guhl S, Guler R, Gustincich S, Ha TJ, Hamaguchi M, Hara M, Hasegawa Y, Herlyn M, Heutink P, Hitchens KJ, Hume DA, Ikawa T, Ishizu Y, Kai C, Kawamoto H, Kawamura YI, Kempfle JS, Kenna TJ, Kere J, Khachigian LM, Kitamura T, Klein S, Klinken SP, Knox AJ, Kojima S, Koseki H, Koyasu S, Lee W, Lennartsson A, Mackay-Sim A, Mejhert N, Mizuno Y, Morikawa H, Morimoto M, Moro K, Morris KJ, Motohashi H, Mummery CL, Nakachi Y, Nakahara F, Nakamura T, Nakamura Y, Nozaki T, Ogishima S, Ohkura N, Ohno H, Ohshima M, Okada-Hatakeyama M, Okazaki Y, Orlando V, Ovchinnikov DA, Passier R, Patrikakis M, Pombo A, Pradhan-Bhatt S, Qin XY, Rehli M, Rizzu P, Roy S, Sajantila A, Sakaguchi S, Sato H, Satoh H, Savvi S, Saxena A, Schmidl C, Schneider C, Schulze-Tanzil GG, Schwegmann A, Sheng G, Shin JW, Sugiyama D, Sugiyama T, Summers KM, Takahashi N, Takai J, Tanaka H, Tatsukawa H, Tomoiu A, Toyoda H, van de Wetering M, van den Berg LM, Verardo R, Vijayan D, Wells CA, Winteringham LN, Wolvetang E, Yamaguchi Y, Yamamoto M, Yanagi-Mizuochi C, Yoneda M, Yonekura Y, Zhang PG, Zucchelli S, Abugessaisa I, Arner E, Harshbarger J, Kondo A, Lassmann T, Lizio M, Sahin S, Sengstag T, Severin J, Shimoji H, Suzuki M, Suzuki H, Kawai J, Kondo N, Itoh M, Daub CO, Kasukawa T, Kawaji H, Carninci P, Forrest ARR, Hayashizaki Y.

Sci Data. 2017 Aug 29;4:170112. doi: 10.1038/sdata.2017.112.

4.

DNA methylation in schizophrenia in different patient-derived cell types.

Vitale AM, Matigian NA, Cristino AS, Nones K, Ravishankar S, Bellette B, Fan Y, Wood SA, Wolvetang E, Mackay-Sim A.

NPJ Schizophr. 2017 Jan 23;3:6. doi: 10.1038/s41537-016-0006-0. eCollection 2017.

5.

A Patient-Specific Stem Cell Model to Investigate the Neurological Phenotype Observed in Ataxia-Telangiectasia.

Stewart R, Wali G, Perry C, Lavin MF, FĂ©ron F, Mackay-Sim A, Sutharsan R.

Methods Mol Biol. 2017;1599:391-400. doi: 10.1007/978-1-4939-6955-5_28.

PMID:
28477134
6.

Cell migration in schizophrenia: Patient-derived cells do not regulate motility in response to extracellular matrix.

Tee JY, Sutharsan R, Fan Y, Mackay-Sim A.

Mol Cell Neurosci. 2017 Apr;80:111-122. doi: 10.1016/j.mcn.2017.03.005. Epub 2017 Mar 9.

7.

Schizophrenia patient-derived olfactory neurosphere-derived cells do not respond to extracellular reelin.

Tee JY, Sutharsan R, Fan Y, Mackay-Sim A.

NPJ Schizophr. 2016 Aug 17;2:16027. doi: 10.1038/npjschz.2016.27. eCollection 2016.

8.

Olfactory ensheathing cells but not fibroblasts reduce the duration of autonomic dysreflexia in spinal cord injured rats.

Cloutier F, Kalincik T, Lauschke J, Tuxworth G, Cavanagh B, Meedeniya A, Mackay-Sim A, Carrive P, Waite P.

Auton Neurosci. 2016 Dec;201:17-23. doi: 10.1016/j.autneu.2016.08.015. Epub 2016 Aug 24.

PMID:
27574816
9.

A Grand Challenge. 2. Phenotypic Profiling of a Natural Product Library on Parkinson's Patient-Derived Cells.

Vial ML, Zencak D, Grkovic T, Gorse AD, Mackay-Sim A, Mellick GD, Wood SA, Quinn RJ.

J Nat Prod. 2016 Aug 26;79(8):1982-9. doi: 10.1021/acs.jnatprod.6b00258. Epub 2016 Jul 22.

10.

Mechanism of impaired microtubule-dependent peroxisome trafficking and oxidative stress in SPAST-mutated cells from patients with Hereditary Spastic Paraplegia.

Wali G, Sutharsan R, Fan Y, Stewart R, Tello Velasquez J, Sue CM, Crane DI, Mackay-Sim A.

Sci Rep. 2016 May 27;6:27004. doi: 10.1038/srep27004.

11.

The Constrained Maximal Expression Level Owing to Haploidy Shapes Gene Content on the Mammalian X Chromosome.

Hurst LD, Ghanbarian AT, Forrest AR; FANTOM consortium, Huminiecki L.

PLoS Biol. 2015 Dec 18;13(12):e1002315. doi: 10.1371/journal.pbio.1002315. eCollection 2015 Dec.

12.

Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage.

Carbajo D, Magi S, Itoh M, Kawaji H, Lassmann T, Arner E, Forrest AR, Carninci P, Hayashizaki Y, Daub CO; FANTOM consortium, Okada-Hatakeyama M, Mar JC.

PLoS One. 2015 Dec 14;10(12):e0144176. doi: 10.1371/journal.pone.0144176. eCollection 2015.

13.

Multipotent human stromal cells isolated from cord blood, term placenta and adult bone marrow show distinct differences in gene expression pattern.

Matigian N, Brooke G, Zaibak F, Rossetti T, Kollar K, Pelekanos R, Heazlewood C, Mackay-Sim A, Wells CA, Atkinson K.

Genom Data. 2014 Nov 28;3:70-4. doi: 10.1016/j.gdata.2014.11.011. eCollection 2015 Mar.

14.

A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations.

Abrahamsen G, Fan Y, Matigian N, Wali G, Bellette B, Sutharsan R, Raju J, Wood SA, Veivers D, Sue CM, Mackay-Sim A.

Dis Model Mech. 2015 Oct 1;8(10):1339. doi: 10.1242/dmm.023002. No abstract available.

15.

Isolating dividing neural and brain tumour cells for gene expression profiling.

Endaya B, Cavanagh B, Alowaidi F, Walker T, de Pennington N, Ng JM, Lam PY, Mackay-Sim A, Neuzil J, Meedeniya AC.

J Neurosci Methods. 2016 Jan 15;257:121-33. doi: 10.1016/j.jneumeth.2015.09.020. Epub 2015 Oct 9.

PMID:
26432933
16.

Discovery of molecular markers to discriminate corneal endothelial cells in the human body.

Yoshihara M, Ohmiya H, Hara S, Kawasaki S; FANTOM consortium, Hayashizaki Y, Itoh M, Kawaji H, Tsujikawa M, Nishida K.

PLoS One. 2015 Mar 25;10(3):e0117581. doi: 10.1371/journal.pone.0117581. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0129412.

17.

The statistical geometry of transcriptome divergence in cell-type evolution and cancer.

Liang C; FANTOM Consortium, Forrest AR, Wagner GP.

Nat Commun. 2015 Jan 14;6:6066. doi: 10.1038/ncomms7066.

18.

Labeling of Cellular DNA with a Cyclosal Phosphotriester Pronucleotide Analog of 5-ethynyl-2'-deoxyuridine.

Huynh N, Dickson C, Zencak D, Hilko DH, Mackay-Sim A, Poulsen SA.

Chem Biol Drug Des. 2015 Oct;86(4):400-9. doi: 10.1111/cbdd.12506. Epub 2015 Jan 31.

PMID:
25557046
19.

Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion.

Dando SJ, Mackay-Sim A, Norton R, Currie BJ, St John JA, Ekberg JA, Batzloff M, Ulett GC, Beacham IR.

Clin Microbiol Rev. 2014 Oct;27(4):691-726. doi: 10.1128/CMR.00118-13. Review.

20.

CCL2 enhances pluripotency of human induced pluripotent stem cells by activating hypoxia related genes.

Hasegawa Y, Tang D, Takahashi N, Hayashizaki Y, Forrest AR; FANTOM Consortium, Suzuki H.

Sci Rep. 2014 Jun 24;4:5228. doi: 10.1038/srep05228. Erratum in: Sci Rep. 2014;4:6385.

Supplemental Content

Loading ...
Support Center